The 'iPhone moment' for obesity treatment – WHEB

Only members with restricted access (ie. academics, asset owners, government and regulatory, independent advisers/trustees and sponsoring employers) can view this article. Please login or join to view.

The world is facing an obesity epidemic and pharmaceutical companies are creating new drugs to help people lose weight. In this article Ben Kluftinger writes about the obesity problem around the globe and how these weight loss drugs on the market are impacting people.

Learn more here

Phone:
01234 388845

Email:
Event enquiries
Finance enquiries
General enquiries
Membership enquiries
Press enquiries
Training enquiries

Address:
226B Oving Road
Chichester
West Sussex
PO19 7EJ

Pensions for Purpose acts as an information centre only. We do not endorse any content published on this website that originated from one of our members. For more information, please see the website terms of use

Tweets by Pensions for Purpose

Keep updated:

The 'iPhone moment' for obesity treatment – WHEB

Ben Kluftinger writes about Novo Nordisk, who are producing the so-called 'miracle' weight loss drug taking popular culture by storm.

Only members with restricted access (ie. academics, asset owners, government and regulatory, independent advisers/trustees and sponsoring employers) can view this article. Please login or join to view.

Sign up to our newsletter